ProUroCare Medical Inc.
PUMD · OTC
12/31/2012 | 12/31/2011 | 12/31/2010 | 12/31/2009 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $822 | $124 | $235 | $2,240 |
| G&A Expenses | $1,160 | $0 | $1,878 | $1,711 |
| SG&A Expenses | $1,160 | $1,419 | $1,878 | $1,711 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1,982 | $1,544 | $2,113 | $3,951 |
| Operating Income | -$1,982 | -$1,544 | -$2,113 | -$3,951 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$977 | -$519 | $2,113 | -$2,993 |
| Pre-Tax Income | -$2,959 | -$2,063 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2,959 | -$2,063 | -$6,019 | -$6,944 |
| % Margin | – | – | – | – |
| EPS | -0.17 | -0.13 | -0.44 | -0.73 |
| % Growth | -30.8% | 70.5% | 39.7% | – |
| EPS Diluted | -0.17 | -0.13 | -0.44 | -0.73 |
| Weighted Avg Shares Out | 17,349 | 16,131 | 13,561 | 9,575 |
| Weighted Avg Shares Out Dil | 17,349 | 16,131 | 13,561 | 9,575 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $5 | $0 |
| Interest Expense | $248 | $120 | $1,368 | $1,221 |
| Depreciation & Amortization | $1 | $1 | $1 | $0 |
| EBITDA | -$2,711 | -$1,943 | -$2,113 | -$3,950 |
| % Margin | – | – | – | – |